Skip to content

A randomized control trial of elective induction at 40 weeks and 41 weeks to prevent prolonged pregnancy.

A randomized controlled trial of elective induction at 40 weeks and 41 weeks to prevent prolonged pregnancy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306581858623
Enrollment
322
Registered
2023-06-23
Start date
2023-06-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

induction of labour to prevent prolonged pregnancy

Interventions

induction at 40 weeks
induction at 41 weeks

Sponsors

IPINNIMO OLUWADARE MARTINS
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancies 2. Cephalic fetal presentation 3. Gestational age of 40 weeks to 41 weeks and 3 days gestation from the first day of the last menstrual period and ultrasound biometry before the 12th week of gestation. 4. Patients who gave consent to participate in the study. 5. Parity of = to 4.

Exclusion criteria

Exclusion criteria: 1. Multiple gestations. 2. Non cephalic presentation 3. Intrauterine fetal death. 4. Previous caesarean section scar. 5. Multiparous of 5 and above 6. Medical conditions in pregnancy e.g hypertension, diabetes mellitus and sickle cell anemia. 7. Pregnancies with fetuses having ultrasound diagnosed congenital abnormalities. 8. Women who had no early ultrasound scan report before 12th weeks 9. Women who declined consent.

Design outcomes

Primary

MeasureTime frame
caesarean section rate

Secondary

MeasureTime frame
Maternal outcomes included vaginal delivery rate, maternal satisfaction, and genital tract laceration. Fetal outcomes included : incidence of macrosomia , birth trauma, meconium staining of amniotic fluid, neonatal intensive care unit admission, APGAR score at 1 and 5 minutes and perinatal death.

Countries

Nigeria

Contacts

Public ContactOLUWADARE MARTINS IPINNIMO

consultant

stilldrdre2000@yahoo.com+2348033748593

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026